BRL-37344

BRL-37344 is a drug which acts as a selective agonist of the β₃ adrenergic receptor,^[1] which has been investigated for various biomedical research applications but never developed for clinical use.^{[2][3][4][5][6][7]}

BRL-37344

Clinical data
Trade names	BRL-37344
Legal status
Legal status	US: Investigational New Drug
Identifiers
IUPAC name 2-[4-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}propyl]phenoxy}acetic acid
CAS Number	114333-71-0
PubChem CID	9841972
ChemSpider	2343
UNII	5DZZ1926YW
ChEBI	CHEBI:131180
ChEMBL	ChEMBL284782
CompTox Dashboard (EPA)	DTXSID101126185
Chemical and physical data
Formula	C19H22ClNO4
Molar mass	363.84 g·mol−1
3D model (JSmol)	Interactive image
SMILES C[C@H](CC1=CC=C(C=C1)OCC(=O)O)NC[C@@H](C2=CC(=CC=C2)Cl)O
InChI InChI=1S/C19H22ClNO4/c1-13(21-11-18(22)15-3-2-4-16(20)10-15)9-14-5-7-17(8-6-14)25-12-19(23)24/h2-8,10,13,18,21-22H,9,11-12H2,1H3,(H,23,24)/t13-,18+/m1/s1 Key:ZGGNJJJYUVRADP-ACJLOTCBSA-N